276 related articles for article (PubMed ID: 26612002)
1. The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro.
Wang H; Gao X; Lu X; Wang Y; Ma C; Shi Z; Zhu F; He B; Xu C; Sun Y
Biosci Rep; 2015; 35(6):. PubMed ID: 26612002
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation.
Booy EP; McRae EK; Koul A; Lin F; McKenna SA
Mol Cancer; 2017 Jun; 16(1):109. PubMed ID: 28651607
[TBL] [Abstract][Full Text] [Related]
5. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.
Han G; Zhang X; Liu P; Yu Q; Li Z; Yu Q; Wei X
Int J Oncol; 2018 Nov; 53(5):2056-2066. PubMed ID: 30132513
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503.
Qi H; Wen B; Wu Q; Cheng W; Lou J; Wei J; Huang J; Yao X; Weng G
Biomed Pharmacother; 2018 Jun; 102():326-332. PubMed ID: 29571017
[TBL] [Abstract][Full Text] [Related]
10. BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro.
Wang S; Zhang X; Yuan Y; Tan M; Zhang L; Xue X; Yan Y; Han L; Xu Z
Eur J Cardiothorac Surg; 2015 Mar; 47(3):439-46. PubMed ID: 24875884
[TBL] [Abstract][Full Text] [Related]
11. Hec1/Ndc80 is overexpressed in human gastric cancer and regulates cell growth.
Qu Y; Li J; Cai Q; Liu B
J Gastroenterol; 2014 Mar; 49(3):408-18. PubMed ID: 23591767
[TBL] [Abstract][Full Text] [Related]
12. TUG1 promotes the development of prostate cancer by regulating RLIM.
Guo BH; Zhao Q; Li HY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
[TBL] [Abstract][Full Text] [Related]
13. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HOTTIP contributes to the progression of prostate cancer by regulating HOXA13.
Zhang SR; Yang JK; Xie JK; Zhao LC
Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):84-8. PubMed ID: 27064878
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer.
Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y
J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864
[TBL] [Abstract][Full Text] [Related]
17. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.
Zhu Z; Song L; He J; Sun Y; Liu X; Zou X
Int J Clin Exp Pathol; 2015; 8(9):10082-91. PubMed ID: 26617715
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt.
Zhai XQ; Meng FM; Hu SF; Sun P; Xu W
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1969-1977. PubMed ID: 30915739
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
Yang J; Li C; Mudd A; Gu X
Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
